|
|
Blood, 15 December 2007, Vol. 110, No. 13, pp. 4360-4366.
Prepublished online as a Blood First Edition Paper on September 18, 2007; DOI 10.1182/blood-2007-07-104604.
Previous Article | Next Article 
Submitted July 31, 2007
Accepted September 15, 2007
Differential co-stimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28-CD45RAhi) CD8+ T Cells
Edward CP Waller, Nicola McKinney, Ray Hicks, Andrew J Carmichael, J.G. Patrick Sissons, and Mark R Wills*
Department of Medicine, University of Cambridge Clinical School, Cambridge, United Kingdom
* Corresponding author; email: mrw1004{at}cam.ac.uk.
In healthy carriers of human cytomegalovirus (HCMV), the virus-specific memory CD8+ T cell population is often dominated by CD28- CD45RAhi cells which exhibit direct ex vivo cytotoxicity but whose capacity for proliferation and generation of further memory cells has been questioned. We show that when highly purified CD28- CD45RAhi CD8+ T cells are stimulated with viral peptide presented by autologous monocytes, the virus-specific T cells show early upregulation of CD137 (4-1BB) and CD278 (ICOS), re-express CD28, and proliferate with similarly high cloning efficiency in limiting dilution analysis as CD28+ CD45ROhi cells or CD28- CD45ROhi cells. Using peptide-pulsed autologous fibroblasts transfected with individual costimulatory ligands as antigen presenting cells, we show that CD137L is a key costimulatory ligand for proliferation of CD28- CD45RAhi CD8+ T cells and not CD80, CD86 or CD275 (ICOSL). Therefore CD28- CD45RAhi CD8+ T cells are not terminally differentiated but require a specific co-stimulatory signal for proliferation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Henson, O. Franzese, R. Macaulay, V. Libri, R. I. Azevedo, S. Kiani-Alikhan, F. J. Plunkett, J. E. Masters, S. Jackson, S. J. Griffiths, et al.
KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells
Blood,
June 25, 2009;
113(26):
6619 - 6628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Sharma, K. G. Elpek, E. S. Yolcu, R.-H. Schabowsky, H. Zhao, L. Bandura-Morgan, and H. Shirwan
Costimulation as a Platform for the Development of Vaccines: A Peptide-Based Vaccine Containing a Novel Form of 4-1BB Ligand Eradicates Established Tumors
Cancer Res.,
May 15, 2009;
69(10):
4319 - 4326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. C. Goodyear, G. Pratt, A. McLarnon, M. Cook, K. Piper, and P. Moss
Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma
Blood,
October 15, 2008;
112(8):
3362 - 3372.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|